These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 29214368)

  • 1. Renal pharmacists' perceptions and current practices of assessing medication adherence in dialysis patients.
    Ghimire S; Banks C; Jose MD; Castelino RL; Zaidi STR
    Int J Clin Pharm; 2018 Feb; 40(1):26-35. PubMed ID: 29214368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication adherence assessment practices in dialysis settings: A survey of renal nurses' perceptions.
    Ghimire S; Banks C; Jose MD; Castelino RL; Zaidi STR
    J Clin Nurs; 2019 Feb; 28(3-4):528-537. PubMed ID: 30091498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence assessment practices in haemodialysis settings: A qualitative exploration of nurses and pharmacists' perspectives.
    Ghimire S; Lee K; Jose MD; Castelino RL; Zaidi STR
    J Clin Nurs; 2019 Jun; 28(11-12):2197-2205. PubMed ID: 30786082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the role of renal pharmacists in outpatient dialysis centres: a qualitative study.
    Salgado TM; Moles R; Benrimoj SI; Fernandez-Llimos F
    Int J Clin Pharm; 2012 Aug; 34(4):569-78. PubMed ID: 22538466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacists' perspectives on monitoring adherence to treatment in Cystic Fibrosis.
    Mooney K; Ryan C; Downey DG
    Int J Clin Pharm; 2016 Apr; 38(2):296-302. PubMed ID: 26715548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring pharmacists' views on an in-pharmacy medication review program in Australia using a mixed-methods design.
    Buss VH; Shield A; Kosari S; Peterson GM; Naunton M
    Int J Clin Pharm; 2020 Dec; 42(6):1385-1395. PubMed ID: 32803556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploratory survey of Florida pharmacists' experience, knowledge, and perception of HIV pre-exposure prophylaxis.
    Shaeer KM; Sherman EM; Shafiq S; Hardigan P
    J Am Pharm Assoc (2003); 2014; 54(6):610-7. PubMed ID: 25343624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication adherence beliefs of U.S community pharmacists.
    Witry MJ
    Res Social Adm Pharm; 2018 May; 14(5):471-478. PubMed ID: 28655492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospital pharmacists' perceived beliefs and responsibilities in indication-based off-label prescribing.
    Basak R; McCaffrey DJ
    Int J Clin Pharm; 2018 Feb; 40(1):36-40. PubMed ID: 29204800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qatar pharmacists' understanding, attitudes, practice and perceived barriers related to providing pharmaceutical care.
    El Hajj MS; Al-Saeed HS; Khaja M
    Int J Clin Pharm; 2016 Apr; 38(2):330-43. PubMed ID: 26758716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing the provision of adherence support by community pharmacists: A structural equation modeling approach.
    Mansoor SM; Krass I; Costa DS; Aslani P
    Res Social Adm Pharm; 2015; 11(6):769-83. PubMed ID: 25749550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of the role of practice pharmacists in Australia: a mixed methods study.
    Baker S; Lee YP; Hattingh HL
    Int J Clin Pharm; 2019 Apr; 41(2):504-515. PubMed ID: 30879214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perceptions and current practices of community pharmacists regarding antimicrobial stewardship in Tasmania.
    Rizvi T; Thompson A; Williams M; Zaidi STR
    Int J Clin Pharm; 2018 Oct; 40(5):1380-1387. PubMed ID: 30069668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacists' attitudes and perceived barriers to provision of adherence support in Australia.
    Mansoor SM; Aslani P; Krass I
    Int J Clin Pharm; 2014 Feb; 36(1):136-44. PubMed ID: 23963542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of targeted medication adherence interventions within a community chain pharmacy practice: The Pennsylvania Project.
    Bacci JL; McGrath SH; Pringle JL; Maguire MA; McGivney MS
    J Am Pharm Assoc (2003); 2014; 54(6):584-93. PubMed ID: 25379980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics: perceptions of hospital pharmacists in Qatar about how it was taught and how it is applied.
    Kheir N; Awaisu A; Gad H; Elazzazy S; Jibril F; Gajam M
    Int J Clin Pharm; 2015 Dec; 37(6):1180-7. PubMed ID: 26337835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community pharmacists' attitudes toward providing care and services to patients with severe and persistent mental illness.
    Watkins A; McKee J; Hughes C; Pfeiffenberger T
    J Am Pharm Assoc (2003); 2017; 57(3S):S217-S224.e2. PubMed ID: 28408170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of community pharmacists in depression management: a survey of attitudes, practices and perceived barriers.
    Shami R; Alam MF; ElHajj MS
    Int J Clin Pharm; 2022 Feb; 44(1):214-226. PubMed ID: 34661831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication monitoring attitudes and perceived determinants to offering medication adherence advice to older hypertensive adults: a factorial survey of community pharmacy interns.
    Dillon P; Smith SM; Gallagher P; Cousins G
    Int J Pharm Pract; 2019 Feb; 27(1):45-54. PubMed ID: 29897646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication adherence perspectives in haemodialysis patients: a qualitative study.
    Ghimire S; Castelino RL; Jose MD; Zaidi STR
    BMC Nephrol; 2017 May; 18(1):167. PubMed ID: 28532480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.